Palantir defies bearish concerns with an asset-light model, and strong profitability backed by an 83% Rule of 40 score. Learn ...

Palantir stock's risen 520% over the past 12 months and 38% over one month. Dr James Fox asks whether he’s missed the boat on ...

Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of ...

Palantir Technologies is highly profitable but currently overvalued, with EV/EBITDA ratio of 676.74 and P/E ratio of 513.78.

Palantir Technologies Inc (NASDAQ:PLTR) hits $300B market cap, up from $20B in 2 years. CEO praises Saudi engineers, ...

We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...

U.S. stock futures edge higher, Nvidia stock continues to climb after surging yesterday on an AI deal with a Saudi firm, and ...

Palantir's stock is seeing a boost from reports that the U.S. and Saudi Arabian governments have reached a new deal that ...

Live Updates Live Coverage Has Ended Palantir Still Gaining Substantial Traction 1:57 pm At a new all-time high, Palantir ...

We recently published a list of 10 Buzzing Stocks After Latest Earnings Season. In this article, we are going to take a look ...

Although Palantir Technologies Inc. (PLTR) stock has a “nosebleed” valuation, it does look attractive, based on the ...

Analyst Mariana Perez Mora released a note to investors, laying out her team’s bullish take on the breakout AI stock. “While ...